Evaluation of the GABAergic nervous system in autistic brain: 123I-iomazenil SPECT study

Brain and Development

Volumn 34, Issue 8, 2012, Pages 648-654

  Mori, Tatsuo ^a   Mori, Kenji ^a   Fujii, Emiko ^a   Toda, Yoshihiro ^a   Miyazaki, Masahito ^a   Harada, Masafumi ^a   Hashimoto, Toshiaki ^b   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Department of Pediatrics Japan Red Cross Tokushima Hinomine Rehabilitation   (Japan)

Author keywords

Aminobutyric acid (GABA); 123I iomazenil SPECT; Autistic spectrum disorders (ASD); Epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; IOMAZENIL I 123;

ADOLESCENT; ARTICLE; ASPERGER SYNDROME; AUTISM; BRAIN SCINTISCANNING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; FOCAL EPILEPSY; FRONTAL CORTEX; GABAERGIC SYSTEM; HUMAN; IMAGE ANALYSIS; INFERIOR FRONTAL GYRUS; INTELLECTUAL IMPAIRMENT; MIDDLE FRONTAL GYRUS; ORBITAL CORTEX; PRESCHOOL CHILD; PROTEIN LOCALIZATION; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPERIOR FRONTAL GYRUS;

ADOLESCENT; BRAIN; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FLUMAZENIL; GAMMA-AMINOBUTYRIC ACID; HUMANS; IODINE RADIOISOTOPES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84864781015     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.10.007     Document Type: Article

References (23)

1. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995, 25:63-77.
2. Descheemaeker M.J., Govers V., Vermeulen P., Fryns J.P. Pervasive developmental disorders in Prader-Willi syndrome: the Leuven experience in 59 subjects and controls. Am J Med Genet A 2006, 140:1136-1142.
3. Scambler D.J., Hepburn S.L., Hagerman R.J., Rogers S.J. A preliminary study of screening for risk of autism in children with fragile X syndrome: testing two risk cut-offs for the Checklist for Autism in Toddlers. J Intellect Disabil Res 2007, 51:269-276.
4. Simon J., Wakimoto H., Fujita N., Lalande M., Barnard E.A. Analysis of the set of GABA(A) receptor genes in the human genome. J Biol Chem 2004, 279:41422-41435.
5. Cook E.H., Courchesne R.Y., Cox N.J., Lord C., Gonen D., Guter S.J., et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998, 62:1077-1083.
6. Gantois I., Vandesompele J., Speleman F., Reyniers E., D'Hooge R., Severijnen L.A., et al. Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis 2006, 21:346-357.
7. Fatemi S.H., Reutiman T.J., Folsom T.D., Thuras P.D. GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 2009, 39:223-230.
8. Oblak A.L., Gibbs T.T., Blatt G.J. Reduced GABA(A) receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res 2010, 1380:218-228.
9. Hashimoto T., Sasaki M., Sugai K., Hanaoka S., Fukumizu M., Kato T. Paroxysmal discharges on EEG in young autistic patients are frequent in frontal regions. J Med Invest 2001, 48:175-180.
10. Onishi Y., Yonekura Y., Tanaka F., Nishizawa S., Okazawa H., Ishizu K., et al. Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time. Eur J Nucl Med 1996, 23:1491-1497.
11. Minoshima S., Frey K.A., Koeppe R.A., Foster N.L., Kuhl D.E. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995, 36:1238-1248.
12. Matsui H., Udaka F., Miyoshi T., Hara N., Tamura A., Oda M., et al. Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson's disease. Acta Neurol Scand 2005, 112:36-41.
13. Mizumura S., Kumita S., Cho K., Ishihara M., Nakajo H., Toba M., et al. Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation. Ann Nucl Med 2003, 17:289-295.
14. Ribak C.E., Harris A.B., Vaughn J.E., Roberts E. Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science 1979, 205:211-214.
15. Savic I., Persson A., Roland P., Pauli S., Sedvall G., Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988, 2:863-866.
16. Johnson E.W., Woods S.W., Zoghbi S., McBride B.J., Baldwin R.M., Innis R.B. Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: potential probe for SPECT brain imaging. Life Sci 1990, 47:1535-1546.
17. Hommer D.W., Skolnick P., Paul S.M. The benzodiazepine/GABA receptor complex and anxiety. Psychopharmacology: The Third Generation of Progress 1987, 977-983. Raven Press, New York. H.Y. Meltzer (Ed.).
18. Sjöholm H., Rosén I., Elmqvist D. Role of I-123-iomazenil SPECT imaging in drug-resistant epilepsy with complex partial seizures. Acta Neurol Scand 1995, 92:41-48.
19. Chugani D.C., Muzik O., Juhász C., Janisse J.J., Ager J., Chugani H.T. Postnatal maturation of human GABAA receptors measured with positron emission tomography. Ann Neurol 2001, 49:618-626.
20. Blair R.J. Responding to the emotions of others: dissociating forms of empathy through the study of typical and psychiatric populations. Conscious Cogn 2005, 14:698-718.
21. Wang A.T., Lee S.S., Sigman M., Dapretto M. Reading affect in the face and voice: neural correlates of interpreting communicative intent in children and adolescents with autism spectrum disorders. Arch Gen Psychiatry 2007, 64:698-708.
22. Fletcher P.C., Happé F., Frith U., Baker S.C., Dolan R.J., Frackowiak R.S., et al. Other minds in the brain: a functional imaging study of "theory of mind" in story comprehension. Cognition 1995, 57:109-128.
23. Happé F., Ehlers S., Fletcher P., Frith U., Johansson M., Gillberg C., et al. 'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport 1996, 8:197-201.